Literature DB >> 13580195

[Treatment of depressive states with special consideration of tofranil, a new antidepressant].

P KIELHOLZ, R BATTEGAY.   

Abstract

Entities:  

Keywords:  DEPRESSION/therapy; TRANQUILIZING AGENTS/therapeutic use

Mesh:

Substances:

Year:  1958        PMID: 13580195

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


× No keyword cloud information.
  14 in total

Review 1.  Antidepressants and suicide: risk-benefit conundrums.

Authors:  David Healy; Chris Whitaker
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

2.  JAUNDICE DURING IMIPRAMINE TREATMENT.

Authors:  P C HOAKEN
Journal:  Can Med Assoc J       Date:  1964-06-13       Impact factor: 8.262

3.  [The effect of imipramine on higher nervous activity in man. An experimental study using the methodology of conditioned reflexes].

Authors:  R ALNAES; A ASLANOV
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1963

4.  Myocardial infarction during imipramine treatment of depression.

Authors:  L SLOMAN
Journal:  Can Med Assoc J       Date:  1960-01-02       Impact factor: 8.262

5.  A controlled trial of imipramine in treatment of depressive states.

Authors:  J R BALL; L G KILOH
Journal:  Br Med J       Date:  1959-11-21

6.  The electrocardiogram and its interpretation: a study of reports by 20 physicians on a set of 100 electrocardiograms.

Authors:  H N SEGALL
Journal:  Can Med Assoc J       Date:  1960-01-02       Impact factor: 8.262

7.  Suicidal attempt by imipramine overdosage.

Authors:  N P LANCASTER; A R FOSTER
Journal:  Br Med J       Date:  1959-12-26

8.  Immunological studies on Behçet's syndrome.

Authors:  T Shimizu; Y Katsuta; Y Oshima
Journal:  Ann Rheum Dis       Date:  1965-09       Impact factor: 19.103

9.  Use of imipramine (tofranil) in the aged chronically ill.

Authors:  M STRAKER; E M ROTH
Journal:  Can Med Assoc J       Date:  1960-02-13       Impact factor: 8.262

10.  The effect of iproniazid and imipramine on the blood platelet 5-hydroxytrptamine level in man.

Authors:  E F MARSHALL; G S STIRLING; A C TAIT; A TODRICK
Journal:  Br J Pharmacol Chemother       Date:  1960-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.